Asahi leads Series A funding round for Embion Technologies

Swiss biotechnology company Embion Technologies has raised CHF 4.5 million in a Series A financing round led by Asahi. 

Embion’s biomass processing technology enables the repurposing of food and agricultural industry byproducts into high-value, nature-derived functional ingredients.

The company’s technology reduces the carbon footprint of food production by supporting upcycling and helping to expand food resources, increasing security and sustainability.

Georgios Savoglidis, co-founder and CEO of Embion, commented: “We are incredibly pleased to have Asahi on board as a lead investor sharing a common vision to accelerate the sustainability of food production and to future-proof food supply security”.

He continued: “The functional nutrition market is evolving rapidly and the timing of the closing of our Series A financing could not be better. It enables us to bring the unique benefits of our platform technology to market faster. Hence, our customers in the health and nutrition industries can offer products that have a positive impact on the planet and the health of its inhabitants.”

Embion plans to use the investment to scale up production capabilities in order to expand the business, and continue securing IP in animal and human health and nutrition. There are also plans to double the size of the company’s team to unlock growth in multiple markets.

Last year, Embion and Asahi announced their partnership to develop new products from brewing byproducts generated by Asahi.